Gebhard Thoma

8PUBLICATIONS
20CO-AUTHORS
GlycoconjugatesCheminformatics and quantitative structure-activity relationshipsToxicology (incl. clinical toxicology)Biologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase.

Gebhard Thoma, Wolfgang Miltz, Rudolf Waelchli

|Mar 13, 2024
Structure-Guided Elaboration of a Fragment-Like Hit into an Orally Efficacious Leukotriene A4 Hydrolase Inhibitor.

Gebhard Thoma, Wolfgang Miltz, Honnappa Srinivas

|Feb 26, 2024
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial.

Christian Loesche, Damien Picard, Benjamin Van Hoorick

|Nov 28, 2023
Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 Hydrolase.

Gebhard Thoma, Christian Markert, Rainer Lueoend

|Oct 31, 2023
Design of a Supersoft Topical JAK Inhibitor, Which Is Effective in Human Skin but Rapidly Deactivated in Blood.

Gebhard Thoma, Odile Decoret, Eric Vangrevelinghe

|Jun 14, 2023
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive Conformation.

Gebhard Thoma, Eric Vangrevelinghe, Alexandre Luneau

Pageof 2